Track topics on Twitter Track topics that are important to you
Astex was founded in 1999 by Harren Jhoti, PhD, former Head of Structural Biology and of UK Bioinformatics at GlaxoWellcome, together with Professor Sir Tom Blundell, FRS, Professor Chris Abell, (both of University of Cambridge) and Dr Roberto Solari, currently Chief Executive of Medical Research Council Technology. The co-founders' vision for Astex was to develop the use of high-throughput X-ray crystallography in a novel fragment-based approach to drug discovery. In only five years, the consistent vision of the co-founders has materialized into a leading European biotechnology company that has pioneered and successfully established this new approach to drug discovery.
Since Astex began its operations it has raised more than £51 million in two principal funding rounds from leading biotech investors in the US and in Europe. Astex operates its business from a purpose-built, 36,000 sq.ft. research and development facility on the Cambridge Science Park in the UK and has a staff of approximately 95 almost 60 of whom have PhD's.
436 Cambridge Science ParkMilton Road
Phone: 44 (0)1223 226200
Fax: 44 (0)1223 226201
In this episode of PharmaTelevision News Review, Fintan Walton talks to Martin Buckland, CBO of Astex Therapeutics
In this episode of PharmaTelevision News Review, Paul Larsmon talks to James Manuso Chairman & CEO and Harren Jhoti President of Astex Pharmaceuticals.
Astex Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance ReportSummaryAstex Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and i...
Cancer Research UK and Newcastle University have extended their strategic drug discovery alliance with Astex Pharmaceuticals by three years to work on developing new cancer drugs and associated biomar...
Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for a further three years. The alliance was formed fiv...
(Institute for Systems Biology Moscow) nSysBio LLC (www.insysbio.ru), one of the pioneers in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, announced today a ren...
Cancer Research UK and Newcastle University have extended their strategic drug discovery alliance with Astex Pharmaceuticals for three years.
Press release Cancer Research UK* and Newcastle University announce a three year extension to their major strategic drug discovery alliance with Astex Pharmaceuticals, a pharmaceutical company ded...
ALDEX GS™ Tablets
ALDEX GS DMTablets
The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...
Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System
The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...
The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...
This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...
Astex was founded in 1999 by Harren Jhoti, PhD, former Head of Structural Biology and of UK Bioinformatics at GlaxoWellcome, together with Professor Sir Tom Blundell, FRS, Professor Chris Abell, (both...
Astex Technology is a structure-based drug discovery company pioneering the use of high throughput X-ray crystallography for the rapid identification of novel drug candidates. The company's unique st...
Astex Pharmaceuticals is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. The Company is developing a proprietary pipeline of novel cancer...
Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...
Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...
We have published hundreds of Astex Therapeutics news stories on BioPortfolio along with dozens of Astex Therapeutics Clinical Trials and PubMed Articles about Astex Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Astex Therapeutics Companies in our database. You can also find out about relevant Astex Therapeutics Drugs and Medications on this site too.
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...